Last updated: August 18, 2024
Sponsor: University of Florence
Overall Status: Active - Recruiting
Phase
N/A
Condition
Prostate Disorders
Interstitial Cystitis
Bladder Disorders
Treatment
Transperineal Laser Ablation of Prostate
Clinical Study ID
NCT06564415
25691
Ages > 18 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥18 years;
Prostate volume ≥ 30 mL;
Moderate-to-severe LUTS according to International Prostatic Symptoms Score (IPSS ≥8)
Consent to participate;
Exclusion
Exclusion Criteria:
Absence of consent;
Subsequent withdrawal of consent;
Diagnosis or suspicion of prostate cancer at multiparametric magnetic resonance
Documented bladder impaired contractility
Urethral stenosis
Previous prostate surgery
Study Design
Total Participants: 2500
Treatment Group(s): 1
Primary Treatment: Transperineal Laser Ablation of Prostate
Phase:
Study Start date:
January 11, 2024
Estimated Completion Date:
January 31, 2034
Connect with a study center
AOU Careggi
Florence, 50134
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.